Keefe Gorman, a wealth management advisor with nearly 30 years of experience, serves as the managing director of investments at Merrill Lynch in Ithaca, New York. In addition to his role at Merrill Lynch, Keefe Gorman supports a number of nonprofit organizations including the Leukemia and Lymphoma Society (LLS).
The Therapy Acceleration Program (TAP) created by the LLS provides funding for research projects exploring new discoveries in the field of blood cancer treatment, diagnosis, and care. TAP is made up of three divisions that award grants to different research approaches.
-The Academic Concierge Division provides support to academic institutions undertaking cancer research. Current projects include a study with Johns Hopkins University to determine if immune system alteration can help patients with multiple myeloma.
-The Biotechnology Accelerator Division supports companies in various stages of developing new cancer treatment options. The division is funding a clinical study of a new treatment for elderly patients with leukemia.
-The Clinical Trials Division helps pair patients with relevant clinical trials. With growing enrollment around the country, more patients are able to participate in these studies. The division works with 11 institutions across the United States.